Načítá se...
Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development
BACKGROUND: Alzheimer’s disease (AD), the most common cause of dementia in adulthood, has great medical, so-cial, and economic impact worldwide. Available treatments result in symptomatic relief, and most of them are indicated from the early stages of the disease. Therefore, there is an increasing b...
Uloženo v:
| Vydáno v: | Curr Neuropharmacol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Science Publishers
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6712290/ https://ncbi.nlm.nih.gov/pubmed/30255758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X16666180926123722 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|